^{Photo: CNBC}

Hinge Health Impresses in First Post-IPO Earnings Report

Hinge Health Inc. (HNGH) saw its stock jump 6% in after-hours trading on Tuesday, after the company released its first quarterly results since going public on the New York Stock Exchange in May. The digital physical therapy firm not only beat Wall Street’s revenue expectations, but also provided a strong forward outlook, signaling investor confidence in its long-term growth potential.

Q2 2025 Financial Highlights

Here’s how Hinge Health performed compared to analyst expectations from LSEG:

• Revenue: $139 million (vs. $125 million expected)
• Net Loss: $575.65 million, or $13.10 per share
• GAAP Operating Loss: $580.7 million, including $591 million in stock-based compensation
• Client Count: 2,359 (up 39% YoY from 1,785)

The company’s Q2 revenue rose 55% from $89.8 million in the same period last year — a sign of growing demand for remote musculoskeletal care.

Despite the massive net loss — driven largely by stock compensation tied to its IPO — the strong top-line growth and expanding client base kept investor sentiment upbeat.

Strong Forecasts for Q3 and Full Year

Hinge Health issued guidance that once again beat consensus estimates:

• Q3 Revenue Forecast: $141 million to $143 million (vs. $129 million expected)
• Full-Year 2025 Revenue Forecast: $548 million to $552 million (vs. $511 million expected)

This indicates continued double-digit growth as the company further penetrates the employer and health plan markets.

CEO Daniel Perez said on the earnings call:

“We believe we’re fundamentally reshaping how care can be delivered more effectively and efficiently.”

A New Model of Care Delivery

Founded in 2014, Hinge Health has been pioneering a tech-first approach to physical therapy. By combining connected hardware, AI-powered exercise programs, and virtual physical therapists, Hinge helps patients recover from surgeries, manage chronic pain, and treat acute injuries — all remotely.

Perez emphasized the long-term vision in an interview with CNBC:

“We’re still introducing ourselves to the world... but our goal is to automate care delivery through intelligent software and hardware integration.”

The company’s business model appeals especially to employers and payers, looking to cut costs and improve outcomes for musculoskeletal (MSK) conditions, which are a leading driver of healthcare spending globally.

Stock Performance Since IPO

Hinge Health debuted on the NYSE in May at $32 per share, opening at $39.25, and closing Tuesday at $48.22, reflecting significant investor optimism.

Despite the deep operating losses, investors appear focused on the scalability of Hinge’s platform, its growing market share, and its first-mover advantage in the digital MSK space.

Final Thoughts

Hinge Health’s debut earnings report signals that the company is hitting the ground running post-IPO. With a rapidly expanding customer base, strong revenue growth, and ambitious future guidance, Hinge is positioning itself as a disruptor in the $213 billion global MSK care market.

The road to profitability may be long, but for now, Wall Street seems willing to bet on its potential to redefine how physical therapy is delivered at scale.

‍